Additionally, the company has initiated a new brepocitinib trial for cutaneous sarcoidosis, marking its third indication for ...

as the treatment and overall prognosis of cutaneous sarcoidosis are primarily dependent on the degree of systemic involvement.

Sirolimus may be an effective treatment for patients with persistent cutaneous sarcoidosis. In a small clinical trial, 7 of 10 patients treated with sirolimus via oral solution had improvements in ...

Gross Professor of Dermatology and the director of Penn's Cutaneous Sarcoidosis & Granulomatous Disease Clinic. "Knowing that type 1 innate lymphoid cells are a biomarker for sarcoidosis should ...

This page lists all known medications that could potentially lead to 'Cutaneous sarcoidosis' as a side effect. It's important to note that mild side effects are quite common with medications.

Chloroquine was found to be of greatest value in the treatment of cutaneous sarcoidosis. 9,10 Thus far, no evidence of respiratory failure has been observed in any of the children, and none have died.

Gross Professor of Dermatology and the director of Penn's Cutaneous Sarcoidosis & Granulomatous Disease Clinic. "Knowing that type 1 innate lymphoid cells are a biomarker for sarcoidosis should ...

an investigational anti-GM-CSF monoclonal antibody administered once-monthly as a subcutaneous injection, in participants with chronic active pulmonary sarcoidosis. Primary Endpoint Details ...

Reference: Redl A, Doberer K, Unterluggauer L, et al. Efficacy and safety of mTOR inhibition in cutaneous sarcoidosis: a single-centre trial. Lancet Rheumatol. 2024;6(2):e81-e91. doi: ...